Companies
U.S.-Approved Deal Expands Microsoft’s AI Footprint in the Middle East
Microsoft announced Monday that it will ship over 60,000 of Nvidia’s most advanced artificial intelligence chips to the United Arab...
Kimberly-Clark and Kenvue Unite to Form Consumer Health Giant
Kimberly-Clark, the maker of household staples like Kleenex and Huggies, has announced plans to acquire Tylenol producer Kenvue in a...
Reddit CEO Says AI Chatbots Aren’t Driving Traffic — Google and Direct Visits Still Lead
Steve Huffman highlights strong user growth, rising ad revenue, and new AI-powered search features amid evolving partnerships with OpenAI and...
Amazon Soars 9% After Beating Q3 Estimates on Strong AWS Growth
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6 Amazon (AMZN) shares surged more than 9% in...
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
Study in eBioMedicine shows strong disease control and survival benefits across multiple tumor types with minimal toxicity Intensity Therapeutics (INTS),...
Core Scientific Scraps $9 Billion Sale to CoreWeave After Shareholder Rejection
Investors cite valuation and deal structure concerns as crypto miner opts to remain independent Crypto miner Core Scientific (CORZ) has...
Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth
Google parent’s revenue surges 16% to $102.4 billion, driven by booming AI partnerships and strong cloud performance Alphabet (GOOGL) delivered...
Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum
Revenue climbs 18% to $77.7 billion as Azure growth and AI integration power record performance Microsoft Corp. (MSFT) reported another...
Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3
Stock drops 6% as heavy AI spending and restructuring clash with investor expectations Meta (META) delivered a mixed third quarter,...
Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240
Achievement validates CAPTN-3 platform scalability and advances IM1240 toward first-in-human clinical trials in 2026 Purple Biotech (PPBT), a clinical-stage biotechnology...
